557 completed. 557 Phase 1, 169 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 557 | Completed 557 |
| Phase 2 | 169 | Completed 169 |
Follow Prostatic Neoplasms: new trials by email Literature Review of Prostatic Neoplasms trials Research Report on Prostatic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety and Dosimetry of Imaging With 68Ga-OncoACP3 in Prostate Cancer [68Ga]Ga-OncoACP3 - Prostate Cancer | Phase 1 | Completed | Philogen S.p.A. | 20 | 2026-05-27 | 2026-10-27 |
| A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects HRS-5041 Tablets, Rifampicin Capsule - Prostate Cancer | Phase 1 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 16 | 2025-06-20 | 2025-09-10 |
| A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults Flotufolastat F-18 Injection - Prostate Cancer | Phase 1 | Completed | Sinotau Pharmaceutical Group | 6 | 2025-06-07 | 2026-11-10 |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer [68Ga]Ga-OncoACP3 - Prostate Cancer, Prostate Cancer Metastatic Disease | Phase 1 | Completed | Philogen S.p.A. | 20 | 2025-04-08 | 2026-01-06 |
| Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio), Lidocaine, Biopsy of Prostate - Prostate Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 350 | 2025-01-09 | 2026-02-17 |
| Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen One single intravenous injection of [177Lu]Lu-BQ7876 - Prostate Cancers | Phase 1 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 7 | 2024-10-01 | 2026-06-26 |
| Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants HRS-5041 dose level 1, HRS-5041 dose level 2 - Prostate Cancer | Phase 1 | Completed | Atridia Pty Ltd. | 24 | 2024-09-25 | 2025-03-18 |
| A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008) [¹⁴C]Opevesostat, Prednisone, Fludrocortisone - Metastatic Prostate Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 8 | 2024-09-19 | 2024-10-23 |
| A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) MK-5684, Prednisone, Fludrocortisone acetate - Prostatic Neoplasms | Phase 1 | Completed | Merck Sharp & Dohme LLC | 12 | 2024-07-11 | 2024-10-15 |
| A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors APL-5125 - Colorectal Cancer, Cholangiocarcinoma | Phase 1 | Completed | Apollo Therapeutics Ltd | 27 | 2024-06-18 | 2026-10-05 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients 68Ga-NYM032 injection - Prostate Cancer | Phase 1 / Phase 2 | Completed | Norroy Bioscience Co., LTD | 20 | 2024-06-04 | 2025-05-21 |
| Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy NeuroSAFE procedure, LaserSAFE procedure - Prostate Cancer | Phase 1 / Phase 2 | Completed | University College, London | 21 | 2024-05-15 | 2025-01-10 |
| A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) Opevesostat, Dexamethasone, Fludrocortisone - Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 14 | 2024-01-30 | 2026-03-19 |
| A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) Opevesostat, Dexamethasone, Fludrocortisone acetate - Prostatic Neoplasms, Metastatic Castration-Resistant Prostate Cancer | Phase 1 | Completed | Merck Sharp & Dohme LLC | 7 | 2023-11-14 | 2026-04-27 |
| Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 Whole body study and SPECT with [99mTc]Tc-BQ0413 - Prostate Cancer | Phase 1 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 10 | 2023-10-19 | 2026-06-24 |
| A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. Saruparib (AZD5305), Darolutamide, No Treatment - Prostate Cancer | Phase 1 | Completed | AstraZeneca | 113 | 2023-09-21 | 2026-06-30 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects SOL-804-F, Zytiga - Prostate Cancer | Phase 1 | Completed | Bukwang Pharmaceutical | 48 | 2023-08-10 | 2024-02-05 |
| Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 Intravenous injection of [99mTc]Tc-DB8 - Prostate Cancer, Breast Cancer | Phase 1 | Completed | Tomsk National Research Medical Center of the Russian Academy of Sciences | 10 | 2023-07-03 | 2026-06-26 |
| A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors SNS-101 (anti-VISTA), Cemiplimab - Solid Tumor, Adult, Advanced Solid Tumor | Phase 1 / Phase 2 | Completed | Sensei Biotherapeutics, Inc. | 98 | 2023-05-31 | 2026-09-02 |
| AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients AGN-Cogni.Q - Prostate Cancer | Phase 1 | Completed | Milton S. Hershey Medical Center | 12 | 2023-05-02 | 2026-06-02 |
Showing 20 of 557. Sign in to see all of them.
Breast Neoplasms (91) · Neoplasms (70) · Carcinoma, Non-Small-Cell Lung (53) · Ovarian Neoplasms (53) · Pancreatic Neoplasms (46) · Urinary Bladder Neoplasms (45) · Colorectal Neoplasms (40) · Lung Neoplasms (39) · Melanoma (35) · Colonic Neoplasms (34) · Neoplasm Metastasis (33) · Esophageal Neoplasms (32) · Head and Neck Neoplasms (31) · Stomach Neoplasms (31)
Urogenital Diseases (557) · Genital Diseases (556) · Male Urogenital Diseases (556) · Neoplasms by Site (554) · Genital Diseases, Male (553) · Genital Neoplasms, Male (553) · Prostatic Diseases (551) · Urogenital Neoplasms (551) · Neoplasms (487) · Skin and Connective Tissue Diseases (106) · Skin Diseases (105) · Female Urogenital Diseases (100) · Female Urogenital Diseases and Pregnancy Complications (100) · Breast Diseases (97) · Neoplasms by Histologic Type (91)
Docetaxel (42) · Prednisone (27) · enzalutamide (21) · Abiraterone Acetate (18) · Radiotherapy (16) · bicalutamide (13) · Goserelin (12) · Leuprolide (10) · Estramustine (8) · Paclitaxel (8) · abiraterone (8) · pembrolizumab (8) · Radiotherapy, Intensity-Modulated (7) · gallium 68 PSMA-11 (7) · sargramostim (7)
National Cancer Institute (NCI) (41) · Memorial Sloan Kettering Cancer Center (32) · M.D. Anderson Cancer Center (11) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (11) · AstraZeneca (10) · Janssen Research & Development, LLC (10) · Weill Medical College of Cornell University (9) · University Health Network, Toronto (8) · Bayer (7) · Millennium Pharmaceuticals, Inc. (7) · Merck Sharp & Dohme LLC (6) · Molecular Insight Pharmaceuticals, Inc. (6) · Pfizer (6) · Astellas Pharma Inc (5) · Bristol-Myers Squibb (5)
United States (406) · Canada (43) · United Kingdom (38) · Spain (15) · Australia (14) · France (13) · Netherlands (13) · Belgium (11) · China (11) · Denmark (11) · Germany (10) · South Korea (10) · Italy (9) · Japan (9) · Norway (6)
Michael Morris, MD (6) · Susan Slovin, MD, PhD (6) · James L Gulley, M.D. (5) · Scott Tagawa, MD (4) · Howard I. Scher, MD (3) · Keith A. Rodvold (3) · Rahul Aggarwal, MD (3) · William K. Kelly, DO (3)
PMID 33465252, PMID 36383907, PMID 19949018, PMID 22002018, PMID 22747660, PMID 25475068, PMID 37496366, PMID 41044356, PMID 10661346, PMID 11828001, PMID 12694838, PMID 14504052, PMID 14529764, PMID 14967428, PMID 15590164, PMID 15671557, PMID 15735119, PMID 15936549, PMID 16145049, PMID 16597660, PMID 17707059, PMID 17920349, PMID 18245546, PMID 18384719, PMID 18464023, PMID 18523152, PMID 19192962, PMID 19349545, PMID 19375217, PMID 19499186, PMID 19577865, PMID 19706807, PMID 20068553, PMID 20179219, PMID 20346578, PMID 20398037, PMID 20398925, PMID 20407240, PMID 20501622, PMID 20598811, PMID 20818327, PMID 20824184, PMID 21106711, PMID 21163871, PMID 21377288, PMID 21414514, PMID 21917625, PMID 21976132, PMID 22044694, PMID 22213823
P30CA008748 (6), 2014 (5), P30CA072720 (4), 2015 (3), 2017 (3), P30CA015083 (3), P30CA016672 (3), P50CA058204 (3), U01CA069856 (3), U01CA069912 (3), P30CA016056 (2), P30CA093373 (2), P30CA124435 (2), R01CA207645 (2), U01CA062505 (2)